NONOF - Novo-Catalent deal to ease Wegovy supply concerns
2024-02-05 15:46:06 ET
More on Catalent, Novo Nordisk, etc.
- Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript
- Biotech And Pharma Diversification Pays Off
- Novo Nordisk: Outlook For Weight Loss Drugs In 2024
- Biggest stock movers today: Nvidia, Air Products and Chemicals, Estee Lauder, 4D Molecular Therapeutics, and more
- Catalent to be acquired by Novo Holdings in $16.5B deal